BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23342927)

  • 1. [Ductal adenocarcinoma of the prostate: a report of 7 cases].
    Hiramatsu K; Tsuzaka Y; Kaneko T; Matsushima H; Homma Y
    Nihon Hinyokika Gakkai Zasshi; 2012 Sep; 103(5):671-4. PubMed ID: 23342927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and therapeutic response of a prostate ductal adenocarcinoma: a still unknown tumour?
    Martorana E; Micali S; Pirola GM; Reggiani Bonetti L; Clò V; Ghaith A; Bianchi G
    Urologia; 2016 Sep; 83(3):163-167. PubMed ID: 27174534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
    Seipel AH; Delahunt B; Samaratunga H; Egevad L
    Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Characteristics of Prostate Ductal Adenocarcinoma in Kyoto University Hospital].
    Nakamura K; Terada N; Kobayashi T; Sugino Y; Yamasaki T; Matsui Y; Imamura M; Okubo K; Kamba T; Yoshimura K; Ogawa O
    Hinyokika Kiyo; 2015 Dec; 61(12):487-91. PubMed ID: 26790762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal prostatic adenocarcinoma: magnetic resonance imaging documenting the effect of hormone-radiotherapy.
    Hardie AD; Naveed MA; Clarke HS
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S55-6. PubMed ID: 24718009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure prostatic papillary adenocarcinoma with ductal features.
    Yamashita S; Inaba Y; Soma F; Katayama Y
    Hinyokika Kiyo; 2005 Mar; 51(3):207-9; discussion 210. PubMed ID: 15852679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
    Seipel AH; Wiklund F; Wiklund NP; Egevad L
    Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of prostatic adenocarcinoma with ductal features].
    Yamashita R; Matsuzaki M; Matsui T; Yamaguchi R; Yuen K; Niwakawa M; Tobisu K
    Nihon Hinyokika Gakkai Zasshi; 2008 Mar; 99(3):525-30. PubMed ID: 18404881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of Ki-67 expression in the differential diagnosis of prostatic intraepithelial neoplasia and ductal adenocarcinoma.
    Rioux-Leclercq N; Leray E; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Epstein JI
    Hum Pathol; 2005 May; 36(5):531-5. PubMed ID: 15948120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
    Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group.
    Bardoscia L; Triggiani L; Sandri M; Francavilla S; Borghetti P; Dalla Volta A; Veccia A; Tomasini D; Buglione M; Valcamonico F; Simeone C; Berruti A; Magrini SM; Antonelli A
    World J Urol; 2021 Apr; 39(4):1161-1170. PubMed ID: 32591899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Proportion of Ductal Component in Ductal Adenocarcinoma of the Prostate.
    Jang WS; Shin SJ; Yoon CY; Kim MS; Kang DH; Kang YJ; Jeong WS; Cho NH; Choi YD
    J Urol; 2017 Apr; 197(4):1048-1053. PubMed ID: 27916712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressing prostate carcinoma.
    Haut MJ; Harryhill JF; Rosenstock J; Warhol MJ; Vitti R
    Oncologist; 2001; 6(2):183-96. PubMed ID: 11306730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer.
    Copp H; Bissonette EA; Theodorescu D
    Urology; 2005 Jun; 65(6):1146-51. PubMed ID: 15922433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic ductal adenocarcinoma presenting as a urethral polyp: a clinicopathological study of eight cases of a lesion with the potential to be misdiagnosed as a benign prostatic urethral polyp.
    Samaratunga H; Letizia B
    Pathology; 2007 Oct; 39(5):476-81. PubMed ID: 17886096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.
    Robinson BD; Epstein JI
    J Urol; 2010 Oct; 184(4):1328-33. PubMed ID: 20723921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic ductal adenocarcinoma: a mini review.
    Epstein JI
    Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
    Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
    Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.